92 related articles for article (PubMed ID: 10083322)
1. On/off switching Fas-ligand gene expression in liver by Cre/Loxp adenovirus vector system.
Fujino M; Li XK; Okuyama T; Funeshima N; Tamura A; Enosawa S; Kita Y; Amano T; Yamada M; Amemiya H; Suzuki S
Transplant Proc; 1999; 31(1-2):753-4. PubMed ID: 10083322
[No Abstract] [Full Text] [Related]
2. Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/Loxp inducible system.
Bilbao G; Zhang H; Contreras JL; Zhou T; Feng M; Saito I; Mountz JD; Curiel DT
Transplant Proc; 1999; 31(1-2):792-3. PubMed ID: 10083340
[No Abstract] [Full Text] [Related]
3. Controlled Fas ligand gene expression by Cre/loxP-mediated switching system: high levels of FasL expression result in lethal hepatitis.
Fujino M; Okuyama T; Li XK; Funeshima N; Tamura A; Enosawa S; Amano T; Amemiya H; Suzuki S
Transplant Proc; 1999 Nov; 31(7):2695-6. PubMed ID: 10578253
[No Abstract] [Full Text] [Related]
4. Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system.
Okuyama T; Fujino M; Li XK; Funeshima N; Kosuga M; Saito I; Suzuki S; Yamada M
Gene Ther; 1998 Aug; 5(8):1047-53. PubMed ID: 10326027
[TBL] [Abstract][Full Text] [Related]
5. Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.
Zhang HG; Bilbao G; Zhou T; Contreras JL; Gómez-Navarro J; Feng M; Saito I; Mountz JD; Curiel DT
J Virol; 1998 Mar; 72(3):2483-90. PubMed ID: 9499110
[TBL] [Abstract][Full Text] [Related]
6. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous on/off regulation of transgenes located on a mammalian chromosome with Cre-expressing adenovirus and a mutant loxP.
Kondo S; Okuda A; Sato H; Tachikawa N; Terashima M; Kanegae Y; Saito I
Nucleic Acids Res; 2003 Jul; 31(14):e76. PubMed ID: 12853653
[TBL] [Abstract][Full Text] [Related]
8. Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination system.
Bennett D; Sakurai F; Shimizu K; Matsui H; Tomita K; Suzuki T; Katayama K; Kawabata K; Mizuguchi H
Mol Pharm; 2012 Dec; 9(12):3452-63. PubMed ID: 23127182
[TBL] [Abstract][Full Text] [Related]
9. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
Tashiro F; Niwa H; Miyazaki J
Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924
[TBL] [Abstract][Full Text] [Related]
10. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
Wang Y; Krushel LA; Edelman GM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3932-6. PubMed ID: 8632992
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Fas-mediated fulminant hepatitis in CrmA gene-transfected mice.
Li XK; Fujino M; Guo L; Okuyama T; Funeshima N; Hashimoto M; Okabe K; Yaginuma H; Mikoshiba K; Enosawa S; Amemiya H; Suzuki S
Biochem Biophys Res Commun; 2000 Jun; 273(1):101-9. PubMed ID: 10873571
[TBL] [Abstract][Full Text] [Related]
12. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system.
Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H
Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells.
Long Q; Yang R; Lu W; Zhu W; Zhou J; Zheng C; Zhou D; Yu L; Wu J
Oncol Rep; 2017 Jan; 37(1):155-162. PubMed ID: 27878291
[TBL] [Abstract][Full Text] [Related]
14. Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma.
Ueda K; Iwahashi M; Nakamori M; Nakamura M; Yamaue H; Tanimura H
Oncology; 2000 Sep; 59(3):255-65. PubMed ID: 11053994
[TBL] [Abstract][Full Text] [Related]
15. Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors.
Okuyama T; Li XK; Funeshima N; Fujino M; Sasaki K; Kita Y; Kosuga M; Takahashi M; Saito H; Suzuki S; Yamada M
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S113-8. PubMed ID: 9792044
[TBL] [Abstract][Full Text] [Related]
16. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers.
Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S
Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 replication by an HIV-1 dependent ribozyme expression vector with the Cre/loxP (ON/OFF) system.
Habu Y; Miyano-Kurosaki N; Nagawa T; Matsumoto N; Takeuchi H; Takaku H
Antivir Chem Chemother; 2002 Sep; 13(5):273-81. PubMed ID: 12630675
[TBL] [Abstract][Full Text] [Related]
18. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro.
Aoki K; Barker C; Danthinne X; Imperiale MJ; Nabel GJ
Mol Med; 1999 Apr; 5(4):224-31. PubMed ID: 10448644
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy for introducing exogenous bcl-2 into neuronal cells: the Cre/loxP system-mediated activation of bcl-2 for preventing programmed cell death using recombinant adenoviruses.
Sato N; Wang S; Li L; Okabe K; Hashimoto M; Yaginuma H; Mikoshiba K; Uchiyama Y; Uetsuki T; Yoshikawa K; Milligan CE; Oppenheim RW
Mol Cell Neurosci; 1998 Sep; 12(1-2):65-78. PubMed ID: 9770341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
